Biotech Archives - Page 35 of 57 - Life Sciences Times

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

May 13, 2025

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

May 12, 2025

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

THIS WEEK'S STORIES

Former New Hampshire Governor Chris Sununu Joins Scope Labs Capital’s Investment Committee

May 9, 2025

FDA Grants Breakthrough Device Status to Prevencio’s AI-Powered Blood Test for Coronary Artery Disease

May 13, 2025

Hims & Hers Names AI Leader Mo Elshenawy as Chief Technology Officer to Drive Next-Gen Healthcare Innovation

May 8, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

CytoTronics Unveils New Cardiac Application for Pixel Platform, Enhancing Drug Discovery in Cardiovascular Research

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

BrightFocus Foundation Awards $13 Million in Grants to Advance Research on Alzheimer’s, Vision Loss

Genentech to Build $700M Manufacturing Facility in North Carolina, Creating Hundreds of Jobs

Epicrispr Biotechnologies Named Finalist in XPRIZE Healthspan Competition for FSHD Innovation

Most Read

K Health’s AI Physician Mode Joins Mayo Clinic Platform to Boost Primary Care Efficiency

FDA Approves GE HealthCare’s Optison for Pediatric Use, Expanding Access to Enhanced Heart Imaging

Vicarious Surgical Partners with UMass Memorial Medical Center to Advance Robotic Surgery Integration

Freespira Gains FDA Clearance for At-Home Anxiety and PTSD Treatment for Adolescents

EDITOR PICKS

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

THIS WEEK'S STORIES

Former New Hampshire Governor Chris Sununu Joins Scope Labs Capital’s Investment Committee

FDA Grants Breakthrough Device Status to Prevencio’s AI-Powered Blood Test for Coronary Artery Disease

Hims & Hers Names AI Leader Mo Elshenawy as Chief Technology Officer to Drive Next-Gen Healthcare Innovation

POPULAR CATEGORY

ABOUT US

FOLLOW US